Clinical Trials Browser

Breast Neoplasms, Recurrence

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Phase NA Recruiting

20 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT07400809 2026-02-17

Retro-COSMOS

Recruiting

350 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT07290972 2026-02-04

NCG-Compliance

Recruiting

618 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Patient Compliance, Recurrence

NCT06961669 2025-05-29

ECAR01

Phase NA Recruiting

18 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Recurrence, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06363591 2025-03-05

WoW

Phase NA Recruiting

2,486 enrolled

Dermatologic

Death, Melanoma, Neoplasm Metastasis, Recurrence

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

44 enrolled

Recurrence

NCT05648019 2023-03-09

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Phase 2 Recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

Phase NA Recruiting

886 enrolled

Gastrointestinal

Recurrence, Stomach Neoplasms

Clinical Trials

RAY-no-BAN

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Retro-COSMOS

NCG-Compliance

ECAR01

WoW

ACCESS-I

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)